Novartis Seeks Approval for New Smoker's Cough Drug - Sept. 27, 2011

Having trouble viewing this email? View in Browser.

Tuesday, September 27, 2011  |   |   |   |  CHI's Ninth International Discovery on Target November 2-4, 2011 | Boston, MA www.DiscoveryOnTarget.com This fall Cambridge Healthtech Institute will host its Ninth International Discovery on Target event showcasing novel "hot" targets for the pharmaceutical industry November 2-4 in Boston, Massachusetts. Advance Registration Discounts are available until this Friday, September 30. Don't miss this opportunity to take advantage of reduced registration rates and save up to $200! This is a must attend event to keep up with current and upcoming developments in target discovery and to collaborate and connect with experienced scientists and high level decision makers. Join us for in-depth coverage of novel drug targets focused on HDAC, RNAi, the PI3K pathways, allosteric modulators, metabolic pathways in tumor cells, kinase inhibitors, GPCR and Diabetes. To register and for up-to-date information, visit www.DiscoveryOnTarget.com. •  Novartis AG (NVS) Seeks Approval for New Smoker's Cough Drug More... •  Talon Therapeutics, Inc. (HNAB)' New Drug Application for Marqibo(R) Accepted for Filing by the FDA More... More BLA/NDA/ANDA News More IND News More MAA News •  Will the FDA Yank Bayer HealthCare Pharmaceuticals (BAYA.F)'s Risky Birth-Control Pill Yaz?; FDA Continues to Monitor Clot Risk Six Months Later More... More Discontinuations News More Recalls and Warning News •  Novartis AG (NVS) Receives Approval in Japan for Two Innovative Therapies, Gilenya(R) in MS and Ilaris(R) in CAPS More... •  Lannett Company, Inc. (LCI) Receives FDA Approval for Loxapine Capsules, 5 MG, 10 MG, 25 MG and 50 MG More... More Drug Approval News •  BioPartners GmbH and LG Life Sciences, Ltd. Present Positive Phase 3, Twenty-Four Months Efficacy and Safety Data for Sustained Release Recombinant Human Growth Hormone (LB03002) Given to Children with Growth Hormone Deficiency More... •  Biodel Inc. (BIOD) Reports Top-Line Results from Pump Study of Experimental Insulins More... •  Enrollment Completed in 22nd Century Group, Inc.'s X-22 Phase II-B Clinical Trial More... •  BioLineRx Ltd. to Present Data from the Successfully Completed Phase IIb Trial of BL-1020 at European Conference on Schizophrenia Research More... •  Transition Therapeutics Inc. (TTH.TO) Announces Publication of ELND005 Phase 2 Clinical Study Data in Alzheimer's Disease More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products to key decision-makers Request Now! •  Childless Men May Face Higher Heart Disease Risk, Stanford University Study More... •  For Women, Risk of Depression Falls as Coffee Intake Rises, Harvard School of Public Health Study More... •  Low Vitamin B12 May Speed Brain Shrinkage, Rush University Medical Center Study More... •  Pivotal Therapeutics Inc. Releases Positive Results from Open Label Study of VASCAZEN(TM) More... •  Brain Needs Serotonin to Restrain Aggression, University of Cambridge Study More... More General Clinical Research News IBC's BioProcess International Conference & Exhibition October 31 - November 4, 2011 - Long Beach, California Event Website Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here. You will see the 2011 program, features a stellar line up keynote presentations including, the US FDA, EMA, Pfizer, Merck and more. Plus, there are over 50 presentations with new, previously unpublished data, and new topic coverage areas including antibody drug conjugates, viral clearance and managing global manufacturing facilities and partners. Register by September 30 and you will save $100 off the standard conference rates with priority code B11171BSEODS2. Exhibit hall & keynote passes are now available. Mention priority code B11171BSEODS2 and the fee will be waived. All passes subject to approval. Register here today or call 800-390-4078 Risk Sharing and Innovative Contracting with CROs • Identify the benefits and challenges of risk sharing & innovative contracting agreements and structure more successful deals. • Analyze compensation and pricing issues in risk sharing agreements, so that negotiations may be more fruitful. • Evaluate the different types of risk sharing and innovative contracting agreements. Click Here for More Information. • Bio NC (Durham, North Carolina) PAREXEL International Senior Biostatistician/ Principal Biostatistician, Clinical Trials Will be charged with the task of producing and delivering analysis plans, reports, derived datasets, tables, listings and figures, providing statistical advice to clients, and fulfilling the project primary role within a designated project team. Interact with clients as key contact with regard to statistical and contractual issues. • Pharm Country (Woodcliff Lake, New Jersey) Eisai Inc. Director, Clinical Development, Frontier PCU Apply medical and clinical development knowledge to transform clinical research ideas into high quality clinical answers. They will provide medical/scientific input to the strategies for clinical studies, being responsible for the key design elements of clinical study protocols, while focusing on innovative design, medical execution and interpretation. • Genetown (Lowell, Massachusetts) PAREXEL International Associate Director Clinical Applications Support EDC, CTMS, Drug Safety Responsible for the delivery of IT Application Support services for PAREXEL'S Clinical Systems application portfolio specializing in Electronic Data Capture ( EDC ), CTMS (Clinical Trial Management Systems), and Safety/Pharmacovigilance, Biostatistics Applications. Leads and manages global application support team to ensure consistent delivery of customer service excellence to all of PAREXEL'S Strategic Business Units. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Clinical Trial Manager / Sr. Clinical Trial Manager, Clinical Program Management Responsible for the execution of Phase II - IV and other approved US and ex-US clinical studies, according to ICH-GCP and required regional regulations as applicable in support of the clinical strategies defined in the Takeda Integrated Development Plan Responsible for the execution of Phase II-IV and other (IDP). • BioCapital (Gaithersbug, Maryland) MedImmune, LLC Associate Director, Clinical Development Create and maintain the CDP for assigned programs ensuring alignment with the Target Product Profile (TPP), accounting for feasibility and regional requirements, capturing health outcomes, epidemiology, and pharmacogenetic considerations. May have a leadership role on clinical teams for assigned programs/projects and may be a representative on the (PDT). Supervise/mentor/advise clinical project team and sub-team members in planning, conducting, data review and cleaning, and evaluating clinical trials. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BioMidwest Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Midwest region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Australia's Agenix Limited Files Key Patent Application for China Hepatitis Drug More... More Patent News •  Watson Pharmaceuticals, Inc. (WPI) Launches Generic FEMCON(R) Fe More... •  Elite Pharmaceuticals, Inc. (ELI) ECR Pharmaceuticals Launch Lodrane D(R) Allergy Product More... More Drug Product News Hot Company SNBL Clinical Pharmacology Center 800 West Baltimore Street, 5th Floor Baltimore, Maryland 21201 U.S.A. Phone: 800-690-9110 Fax: 410-706-8963 SNBL-CPC partners with pharmaceutical companies, biotech firms and CROs to accelerate drug development utilizing our best-in-class facility, technology, operational excellence and strong affiliations with local academic medical institutions (University of Maryland and Johns Hopkins University). More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.